HOME › DRUGS › AMIVANTAMAB-VMJW
ACTIVE SUBSTANCE / INN

AMIVANTAMAB-VMJW

Brand name(s): RYBREVANT
FDA LISTED
PRESCRIPTION
BLA761210
ACTIVE SUBSTANCE
Amivantamab-Vmjw
REGULATORS
FDA
SPONSORS / MAH
JANSSEN BIOTECH
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RYBREVANTBLA761210JANSSEN BIOTECHPrescription

FULL INTELLIGENCE ON AMIVANTAMAB-VMJW

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →